Health Care Equipment & Services

USBC Holdings appoints Martin Pyrgos to lead Interiors division, hoping to spark growth and boost investor confidence in its health‑care tech business.

Edwards Lifesciences sees analyst optimism with $103 price targets amid legal setbacks that could impact its IP strategy, urging investors to weigh growth versus risk.

Discover how Cencora’s $3 billion senior notes boost growth, reshape its balance sheet, and impact shareholder value—insights into risk, strategy, and market sentiment.

DIAGNOS Inc‑Canada pioneers retinal image analysis, boosting diagnostic accuracy and transforming healthcare tech with its knowledge‑extraction platform.

MedMira Inc’s rapid‑diagnostic tech faces dire financial risk—negative P/E and P/B ratios, volatile stock, and low market cap raise urgent investor concerns.

Explore why Cochlear Ltd (ASX: COH) remains a top health‑care equipment pick, with strong ETF inclusion, solid P/E, and growing implant tech.

Inspire Medical Systems hits Q4 2025 record revenue, launches MRI‑compatible V‑system, but faces regulatory probes and reimbursement headwinds—2026 outlook $950‑$1B.

Advanced Biomed Inc’s Nasdaq stock shows sharp volatility—from $4.10 highs to $0.211 lows—while a recent $23k Hong Kong subsidiary sale hints at strategic restructuring.

Beyond Air, Inc. explores nitric‑oxide therapies for respiratory disease but faces volatile stock and negative earnings—high‑risk but potentially breakthrough.

Investors eye Sienna Senior Living’s steady 2.9% dividend, underscoring reliable cash flow from Ontario senior‑care assets amid a growing demand for long‑term care.